AVALO THERAPEUTICS, INC. (AVTX)

Sullivan Christopher Ryan 🟡 adjusted position in 47.0K shares (1 derivative) of Avalo Therapeutics, Inc. (AVTX) at $22.57 ($1.7M) Transaction Date: May 06, 2026 | Filing ID: 000010